BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 18, 2026
Home » Authors » Don Long

Articles by Don Long

MIVT sees continuing strong clinical data for its polymer-free DES

Sep. 1, 2008
By Don Long

The BB&T interview: Carolyn Clancy – RESEARCH & QUALITY GURU

Sep. 1, 2008
By Don Long
Carolyn Clancy, MD, is director of the Agency for Healthcare Research and Quality (AHRQ; Washington), a U.S. Department of Health and Human Services unit charged with analyzing the nation's healthcare activities to facilitate improvement. She joined the agency in 1990, working first as director of its Center for Outcomes and Effectiveness Research. She was named acting director in March 2002, the official appointment as director coming in early 2003. (Biomedical Business & Technology)
Read More

FTC workshops probe 'quality' for any impact on healthcare

Aug. 29, 2008
By Don Long

Colorado biosciences sector shows a healthy growth rate

Aug. 28, 2008
By Don Long
The "Mile High" city will attract the attention of the nation this evening as Sen. Barack Obama accepts the Democratic Party's nomination for U.S. president at Denver's Invesco field. And Colorado is using that attention to boost as well its status and strength in bioscience and med-tech, with the recent rollout of metrics underlining that strength. (Medical Device Daily)
Read More

New group is launched to push cell phones into healthcare IT

Aug. 27, 2008
By Don Long

Coalition lobbies Dems for single-pay, universal coverage

Aug. 26, 2008
By Don Long
The Democratic and Republican national conventions to crown U.S. presidential candidates have become largely media events. And a major healthcare coalition is using a successful media product – one of the best-selling documentaries of all time – to launch a lobbying effort at this year's Democratic gathering to push the approval of single-pay, universal healthcare coverage for all Americans. (Medical Device Daily)
Read More

Power3 banners nearing first definitive Alzheimer's test

Aug. 21, 2008
By Don Long

FDA's draft view of BPA not health activist-friendly

Aug. 21, 2008
By Don Long

Medtronic defines 1Q09 report as a 'market-leading' effort

Aug. 20, 2008
By Don Long

Power3 banners nearing first definitive test for Alzheimer's

Aug. 14, 2008
By Don Long
Previous 1 2 … 13 14 15 16 17 18 19 20 21 … 60 61 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 17, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing